Alas, the miracle did not happen, as clinical trials of the new drug is not in the public domain, and its effectiveness is doubtful
With the onset of autumn, many countries around the world are preparing for the second wave of the coronavirus pandemic. At the time of writing, Russia is the fourth largest in the world in terms of the number of Covid-19 cases detected. Let me remind you that earlier it was Russia that became the first country in the world to register a vaccine against the new coronavirus infection - Sputnik V. Moreover, as it became known in the second half of September, soon in Russian pharmacies it will be possible to buy a drug against Covid-19 called "Areplivir". Retail cost, as RBC reports, will be more than 12 thousand rubles for packaging with forty tablets of 200 mg. We tell what is known about the new drug and whether to run for it in the pharmacy.
"Two drugs for the treatment of Russian-made coronavirus have been allowed for sale in pharmacies, which will allow the treatment of this infection at home," the Ministry of Health said in a statement to the state news agency RIA Novosti. Both drugs are Russian variants of favipiravir, a generic version of a flu virus drug developed by Japanese company Fujifilm.
As writes, clinical trials of the pill drug "Areplivir" showed a reduction in recovery times in patients with coronavirus, although it is officially recommended for the treatment of the virus only Russia, India and China.
One of the approved drugs, registered under the brand name "Areplivir" from September 21, 2020 will appear on the pharmacy shelves of most Russian regions, confirmed the representative of the manufacturer "Promomed". It is expected that at the same time there will be another drug - Coronavir. According to the manufacturer Coronavir, the drug minimizes complications associated with Covid-19.
There is currently no covid-19 drug in the world
So, let's try to understand whether to buy a new Russian drug - you will agree, before you allocate 12,320 rubles from the budget for a new drug, you want to know about it if not all, then as much as possible. Personally, I will add that judging by all the available information about "Areplivir", it is not necessary to do this - at least not yet. One of the first and most important arguments in favor of saving money is the question of the effectiveness of the drug.
"More than 50% of patients who took part in the clinical study showed improvement after seven days of treatment, which is 1.5 times better than in the control group, which did not take the drug," - these words of the manufacturer "Areplivira" quote almost all Russian media, who wrote about the new drug against Covid-19. At the same time, during the preparation of this material, I was not able to find a link to clinical studies of the new drug.
As scientists around the world work on a coronavirus vaccine, WHO experts warn that the worst is yet to come
Meanwhile, the Ministry of Health approved another brand of favipiravir - Avifavir, although its production was mainly export-oriented, and deliveries were made to neighboring Belarus and Kazakhstan. The article quotes experts as saying that it is too early to talk about the effectiveness of the drug:
The results of the research are not published, the methodology of its conduct is not described, and in the scientific world until you see the publication in an authoritative scientific journal, it is too early to say - it is a little populism.
Yulia Tkachenko, Deputy Executive Director for BestDoctor Copper Direction, told Gazeta.ru
It should also be noted that both areplivivir and avifavir are generics, medicines that contain a chemical - the active ingredient (the same favipiravir) identical to the patented original developer (Fujifilm), so it is not entirely advisable to compare their effectiveness.
Well, frankly - the lack of open access to clinical studies antiviral drug "Areplivir" (Coronavir and others) makes only doubt its effectiveness, and the high cost of the drug resembles the sky-high prices for fuflomycin - drugs with unproven effectiveness.
As sad as it may be for me to write these lines, it is not the first time that the Ministry of Health has recommended for the sale of drugs with unproven effectiveness. For example, homeopathic drugs such as Ocyllococcinum and Arbidol have even been included in the UNWLP list, although they do not have any active substance at all. Well, except for liver extract of a fictional barberry duck (ocyllococcinum) or umiphenovir hydrochloride (arbidol)effective drugs against colds andFlu.
Footage from the wonderful British miniseries "Sick Behavior"
I also want to remind you that at the moment there is no cure for colds in the world. So the next time the doctor in the clinic will prescribe you arbidol, boldly look for another doctor. Or at least don't spend money on drugs you'll be fine without. Previously, we wrote - strongly recommend to read.
Returning to Areplivir, I note the following: as The Moscow Times writes, many patients with severe covid-19 in Russia may be offered outpatient treatment with Areplivir, which is expected to reduce the pressure on the Russian health sector and free up places in hospitals. Although our country has placed high stakes on the Sputnik-V vaccine, which is currently in the final stages of testing, many remain sceptical about not vaccinating. Well, time will tell.
